We demonstrate that these inhibitors suppress SLC15A4-mediated endolysosomal TLR and NOD features in many different human and mouse immune cells; we provide evidence in their power to suppress inflammation in vivo As well as in medical configurations; and we provide insights into their system of action. Our conclusions set https://prussiap530jsa8.blogcudinti.com/profile